Page results
-
At UCLH we use many different drugs to treat patients with cancer. Chemotherapy is the treatment of cancer with drugs designed to control or destroy the growth of the tumour.
-
Evidence shows that in selected cases open fetal surgery to close the spina bifida defect improves baby outcomes compared to surgery after birth.
-
The Preterm Birth Clinic is one of a few UK specialist antenatal services that are designed specifically for the needs of pregnant women at risk of premature labour.
-
UCLH is a specialist centre for the treatment of urological cancers.
-
The heart failure service provides comprehensive care for patients with heart failure.
-
The rapid access chest pain clinic provides a quick and early specialist cardiology assessment for patients who need urgent assessment.
-
The head and neck speech and language therapy team provide a highly specialist service to both inpatients and outpatients who may experience difficulty swallowing or speaking following treatment for head and neck cancer.
-
The UK Chagas Hub brings together healthcare professionals, researchers, advocates and members of the Latin American community to tackle Chagas disease in the UK and contribute to global efforts to eliminate the disease.
-
We provide a wide range of general paediatric services, led by a team of enthusiastic consultants and dedicated nurses.
-
The UCLH play and youth services team provides therapeutic, diagnostic, developmental and specialised play interventions to help support children and young people during their time at UCLH.
File results
-
FOI/2023/0386 - Sickle Cell staffing and patients
-
FOI/2023/0384 - Cyber security attacks 2020-2022
-
FOI/2023/0383 - Cataract referrals
-
FOI/2023/0380 - Flexible nurse bank rates/ spend March 2023
-
FOI/2023/0379 - MDT meetings in relation to tailgut cysts
-
FOI/2023/0376 - Director of Estate and Facilities/ Head of Patient Experience contact details
-
FOI/2023/0082 - Organisation structure for Performance and Planning department
-
FOI/2023/0081 - Biometric technology wearables/ data collection
-
FOI/2023/0080 - Treatment for Myeloid leukaemia (AML) and chronic lymphocytic leukaemia
-
FOI/2023/0083 - Software systems/ suppliers used at Trust